Fulvestrant (Faslodex™) as hormonal treatment in postmenopausal patients with advanced breast cancer (ABC) progressing after treatment with tamoxifen and non-steroidal aromatase inhibitors: An ongoing phase II SAKK trial
- 1 March 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (11) , S98
- https://doi.org/10.1016/s0959-8049(02)80309-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: